Revenue
No reported data
Vicapsys Life Sciences, Inc. (VICP)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
Financial statements
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Research & development | $15,267 | $13,097 | $17,698 | $102,180 | $98,983 |
| Operating expenses | $1.0M | $984,790 | $336,871 | $765,844 | $1.0M |
| Operating income | −$1.0M | −$984,790 | −$336,871 | −$765,844 | — |
| Net income | −$1.2M | −$984,790 | −$236,871 | −$765,844 | −$1.4M |
| Basic EPSper diluted share | -$0.03 | -$0.03 | -$0.01 | -$0.04 | -$0.13 |
| Diluted EPSper diluted share | -$0.03 | -$0.03 | -$0.01 | -$0.04 | -$0.13 |